» Articles » PMID: 38340735

Persistent SARS-CoV-2 Infection: Significance and Implications

Abstract

SARS-CoV-2 causes persistent infections in a subset of individuals, which is a major clinical and public health problem that should be prioritised for further investigation for several reasons. First, persistent SARS-CoV-2 infection often goes unrecognised, and therefore might affect a substantial number of people, particularly immunocompromised individuals. Second, the formation of tissue reservoirs (including in non-respiratory tissues) might underlie the pathophysiology of the persistent SARS-CoV-2 infection and require new strategies for diagnosis and treatment. Finally, persistent SARS-CoV-2 replication, particularly in the setting of suboptimal immune responses, is a possible source of new, divergent virus variants that escape pre-existing immunity on the individual and population levels. Defining optimal diagnostic and treatment strategies for patients with persistent virus replication and monitoring viral evolution are therefore urgent medical and public health priorities.

Citing Articles

Risk prediction and early intervention strategies for persistent SARS-CoV-2 infection in patients with non-Hodgkin lymphoma: a retrospective cohort study.

Zou W, Zhang J, Li Y, Cao Y, Li J, Zhang Z BMC Pulm Med. 2025; 25(1):122.

PMID: 40089712 DOI: 10.1186/s12890-025-03524-0.


Respiratory long COVID in aged hamsters features impaired lung function post-exercise with bronchiolization and fibrosis.

Heydemann L, Ciurkiewicz M, Stork T, Zdora I, Hulskotter K, Gregor K Nat Commun. 2025; 16(1):2080.

PMID: 40021627 PMC: 11871369. DOI: 10.1038/s41467-025-57267-x.


The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran.

Shabani M, Nejati A, Yavarian J, Sadeghi K, Zadheidar S, Ahmadi A Front Microbiol. 2025; 15:1531712.

PMID: 39943963 PMC: 11815659. DOI: 10.3389/fmicb.2024.1531712.


Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis.

Themlaoui A, Ancora M, Ghedira K, Mhalla Y, Hamdoun M, Bahri M Viruses. 2025; 17(1).

PMID: 39861838 PMC: 11768452. DOI: 10.3390/v17010046.


Evaluation of Inflammatory Markers and Clinical Outcomes in COVID-19 Patients with Concurrent Infection: A Comparative Cohort Analysis.

Ignuta F, Vlad A, Cerbulescu T, Loredana S, Bratosin F, Rosca O Biomedicines. 2025; 13(1.

PMID: 39857695 PMC: 11762707. DOI: 10.3390/biomedicines13010111.